340B Drug Pricing Program
E163275
The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
All labels observed (1)
| Label | Occurrences |
|---|---|
| 340B Drug Pricing Program canonical | 2 |
How this entity was disambiguated
This entity first appeared as the object of triple T1428853 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: 340B Drug Pricing Program Context triple: [Health Resources and Services Administration, oversees, 340B Drug Pricing Program]
-
A.
Prescription Drug Take Back Program
The Prescription Drug Take Back Program is a U.S. Drug Enforcement Administration initiative that provides safe, convenient, and responsible ways for the public to dispose of unused or expired prescription medications.
-
B.
Center for Medicare and Medicaid Innovation
The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
E.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: 340B Drug Pricing Program Target entity description: The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
-
A.
Prescription Drug Take Back Program
The Prescription Drug Take Back Program is a U.S. Drug Enforcement Administration initiative that provides safe, convenient, and responsible ways for the public to dispose of unused or expired prescription medications.
-
B.
Center for Medicare and Medicaid Innovation
The Center for Medicare and Medicaid Innovation is a federal agency within CMS that tests and implements new payment and service delivery models to improve quality and reduce costs in Medicare, Medicaid, and CHIP.
-
C.
NIDA Drug Supply Program
The NIDA Drug Supply Program is a U.S. government initiative that provides researchers with controlled substances and related materials to support scientific studies on drug abuse and addiction.
-
D.
Ryan Haight Online Pharmacy Consumer Protection Act of 2008
The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 is a U.S. federal law that regulates internet pharmacies by requiring valid prescriptions and in-person medical evaluations before dispensing controlled substances online.
-
E.
Medicare Part D
Medicare Part D is the U.S. federal program that provides outpatient prescription drug coverage to Medicare beneficiaries through private insurance plans.
- F. None of above. chosen
Statements (51)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. federal drug discount program
ⓘ
healthcare financing mechanism ⓘ |
| administeredBy |
Health Resources and Services Administration
ⓘ
Office of Pharmacy Affairs ⓘ |
| allows | use of contract pharmacies by covered entities ⓘ |
| appliesTo |
certain outpatient clinic-administered drugs
ⓘ
outpatient prescription drugs ⓘ |
| authorizedBy | Section 340B of the Public Health Service Act ⓘ |
| complianceMechanism | manufacturer participation in Medicaid and Medicare Part B ⓘ |
| controversy |
debates about transparency and use of savings
ⓘ
disputes over scope of contract pharmacy use ⓘ manufacturer restrictions on 340B pricing at contract pharmacies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| coveredEntityType |
FQHC look-alikes
ⓘ
Native Hawaiian Health Centers ⓘ Ryan White HIV/AIDS Program ⓘ
surface form:
Ryan White HIV/AIDS Program grantees
Title X family planning clinics ⓘ children’s hospitals ⓘ critical access hospitals ⓘ disproportionate share hospitals ⓘ federally qualified health centers ⓘ freestanding cancer hospitals ⓘ hemophilia treatment centers ⓘ rural referral centers ⓘ sole community hospitals ⓘ tribal and urban Indian health programs ⓘ |
| createdBy |
United States Congress
ⓘ
surface form:
U.S. Congress
|
| discountBasis | Medicaid drug rebate program pricing ⓘ |
| discountFormulaIncludes |
Average Manufacturer Price
ⓘ
unit rebate amount ⓘ |
| effectiveFrom | 1992 ⓘ |
| eligibilityCriterion | entity must be a covered entity as defined in Section 340B ⓘ |
| enactedAsPartOf | Veterans Health Care Act of 1992 ⓘ |
| governingLaw | Public Health Service Act ⓘ |
| intendedBeneficiary |
low-income patients
ⓘ
underinsured patients ⓘ uninsured patients ⓘ |
| purpose |
to enable covered entities to stretch scarce federal resources
ⓘ
to reduce outpatient drug costs for eligible providers ⓘ to support care for uninsured and underinsured patients ⓘ |
| regulator |
Health Resources and Services Administration
ⓘ
United States Department of Health and Human Services ⓘ
surface form:
U.S. Department of Health and Human Services
|
| relatedAgency | Centers for Medicare & Medicaid Services ⓘ |
| relatedProgram | Medicaid Drug Rebate Program ⓘ |
| requires |
covered entities to prevent diversion of drugs to ineligible patients
ⓘ
covered entities to prevent duplicate discounts with Medicaid rebates ⓘ drug manufacturers to provide outpatient drugs at discounted prices ⓘ manufacturers to sign a Pharmaceutical Pricing Agreement with HHS ⓘ |
| subjectTo |
HRSA audits of covered entities
ⓘ
manufacturer audits under certain conditions ⓘ |
| supports | safety-net providers ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: 340B Drug Pricing Program Description of subject: The 340B Drug Pricing Program is a U.S. federal initiative that requires drug manufacturers to provide outpatient medications to eligible healthcare organizations at significantly reduced prices to support care for underserved patients.
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.